Prasugel or Clopidogrel Based on a Chronological Age Cutoff in Two Older Men after Percutaneous Coronary Intervention

Editor's Note: Please see associated Expert Analysis

Patient 1:
A 70-year-old Caucasian man with multiple chronic conditions/multimorbidity,1,2 without a prior history of stroke or TIA, body mass index of 26 kg/m2 (77 kg) presents with angina pectoris and a surface ECG showing anterior ST-elevation myocardial infarction (STEMI). While obtaining a focused medical history, in preparation for transport to the cardiac catheterization laboratory, he and his family state that he has been slowing down (having trouble crossing a street in the allotted time, low overall physical activity, weight loss over the past year). He is transported to the cardiac catheterization where a drug eluting stent is placed across the proximal left anterior descending artery.

Patient 2:
A 76-year-old Hispanic man with multimorbidity,1 without a prior history of stroke or TIA, body mass index of 26 kg/m2 (77 kg) presents with angina pectoris and a surface ECG showing anterior ST-elevation myocardial infarction (STEMI). While obtaining a focused medical history, in preparation for transport to the cardiac catheterization laboratory, he and his family are surprised that he is having a heart attack. Prior to this, they state he has been physically active playing doubles tennis 4-5 times a week, and golfing once a week. He is transported to the cardiac catheterization where a drug eluting stent is placed across the proximal left anterior descending.

At the end of the procedure you are deciding between prasugrel or clopidogrel as an optimal antiplatelet therapy. You remember that the drug monograph states that prasugrel is generally not recommended in patients over 75 year of age.

Regarding a continuous variable such as chronological age (or weight) which of the following statements is FALSE?

Show Answer